Daivobet ointment, 30 g
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Ireland
Package quantity, pcs
one
Daivobet ointment 30g tube
Name ENG
DAIVOBET
Clinical and pharmacological group
Antiproliferative and anti-inflammatory drug for the treatment of psoriasis
ATX code
Calcipotriol in combination with other drugs
Dosage
500mcg + 50mcg x 30g
Structure
1 g of ointment for external use contains:
Active substances: betamethasone dipropionate 643 mcg, equivalent to 500 mcg of betamethasone
calcipotriol monohydrate 52 μg, equivalent to calcipotriol 50 μg.
Excipients: liquid paraffin, polyoxypropylene-15-stearyl ether, β-tocopherol, white soft paraffin.
Indications
Chronic vulgar plaque psoriasis.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
after opening - 6 months
INN / Active ingredient
Calcipotriol + Betamethasone
Contraindications
Diseases accompanied by impaired calcium metabolism
severe renal and hepatic failure
viral (including herpes or chickenpox) infections
fungal infections of the skin
bacterial skin infections
parasitic skin infections
rosacea
rosacea
acne vulgaris
perioral dermatitis
cutaneous manifestations of tuberculosis and syphilis
skin atrophy
skin ulcers
increased fragility of skin vessels
ichthyosis
perianal and genital itching
psoriatic erythroderma
teardrop, exfoliative, pustular psoriasis
hypersensitivity to drug components.
Specifications
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Ireland
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
18 years
Way of introduction
Outwardly
,
On the skin
Vacation conditions
Without recipe
Brand name
LEO Laboratoris Limited
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Psoriasis cure
Anatomical and therapeutic characteristics
D05AX52 Calcipotriol, in combination with other drugs
Dosage form
Ointment for external use
Packaging
Box
The target audience
Adult
Expiration date in days
730
Package weight, g
2
Mode of application
:
Adults: the topical ointment is applied in a thin layer to the affected skin 1 time / day.
The maximum daily dose is no more than 15 g, the maximum weekly dose should not exceed 100 g. The recommended duration of treatment is 4 weeks.
It is possible to carry out repeated courses of treatment under the supervision of a doctor.
The area of application of the drug should not exceed 30% of the body surface.
Dosage (volume) of the substance in the preparation
:
1 g: betamethasone dipropionate 643 mcg, equivalent to 500 mcg of betamethasone
calcipotriol monohydrate 52 mcg, equivalent to calcipotriol 50 mcg